SE9602145D0 - New improved formulation for treatment of thromboembolism - Google Patents
New improved formulation for treatment of thromboembolismInfo
- Publication number
- SE9602145D0 SE9602145D0 SE9602145A SE9602145A SE9602145D0 SE 9602145 D0 SE9602145 D0 SE 9602145D0 SE 9602145 A SE9602145 A SE 9602145A SE 9602145 A SE9602145 A SE 9602145A SE 9602145 D0 SE9602145 D0 SE 9602145D0
- Authority
- SE
- Sweden
- Prior art keywords
- treatment
- thromboembolism
- formulation
- new improved
- improved formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9602145A SE9602145D0 (sv) | 1996-05-31 | 1996-05-31 | New improved formulation for treatment of thromboembolism |
IDP971453A ID19472A (id) | 1996-05-31 | 1997-05-01 | Formulasi perbaikan baru untuk pengobatan tromboembolisme |
ZA9704386A ZA974386B (en) | 1996-05-31 | 1997-05-20 | New formulation for treatment of thromboembolism. |
ARP970102135A AR013569A1 (es) | 1996-05-31 | 1997-05-20 | Nueva formulacion mejorada para el tratamiento de la tromboembolia |
CA002253410A CA2253410A1 (en) | 1996-05-31 | 1997-05-28 | New improved formulation for treatment of thromboembolism |
AT97926326T ATE284706T1 (de) | 1996-05-31 | 1997-05-28 | Neue verbesserte formulierung zur behandlung von thromboembolismus |
PCT/SE1997/000914 WO1997045138A1 (en) | 1996-05-31 | 1997-05-28 | New improved formulation for treatment of thromboembolism |
NZ332788A NZ332788A (en) | 1996-05-31 | 1997-05-28 | Composition for the treatment of thromboebolism |
EP97926326A EP1015022B1 (de) | 1996-05-31 | 1997-05-28 | Neue verbesserte formulierung zur behandlung von thromboembolismus |
AU31115/97A AU722450B2 (en) | 1996-05-31 | 1997-05-28 | New improved formulation for treatment of thromboembolism |
US08/894,615 US6673365B1 (en) | 1996-05-31 | 1997-05-28 | Formulation for treatment of thromboembolism |
DE69731981T DE69731981T2 (de) | 1996-05-31 | 1997-05-28 | Neue verbesserte formulierung zur behandlung von thromboembolismus |
JP09542227A JP2000511526A (ja) | 1996-05-31 | 1997-05-28 | 血栓症の処置のための新規改良組成物 |
NO985558A NO985558D0 (no) | 1996-05-31 | 1998-11-27 | Ny forbedret formulering for behandling av tromboembolisme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9602145A SE9602145D0 (sv) | 1996-05-31 | 1996-05-31 | New improved formulation for treatment of thromboembolism |
Publications (1)
Publication Number | Publication Date |
---|---|
SE9602145D0 true SE9602145D0 (sv) | 1996-05-31 |
Family
ID=20402816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9602145A SE9602145D0 (sv) | 1996-05-31 | 1996-05-31 | New improved formulation for treatment of thromboembolism |
Country Status (14)
Country | Link |
---|---|
US (1) | US6673365B1 (de) |
EP (1) | EP1015022B1 (de) |
JP (1) | JP2000511526A (de) |
AR (1) | AR013569A1 (de) |
AT (1) | ATE284706T1 (de) |
AU (1) | AU722450B2 (de) |
CA (1) | CA2253410A1 (de) |
DE (1) | DE69731981T2 (de) |
ID (1) | ID19472A (de) |
NO (1) | NO985558D0 (de) |
NZ (1) | NZ332788A (de) |
SE (1) | SE9602145D0 (de) |
WO (1) | WO1997045138A1 (de) |
ZA (1) | ZA974386B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6462021B1 (en) | 2000-11-06 | 2002-10-08 | Astrazeneca Ab | Use of low molecular weight thrombin inhibitor |
SE0203349D0 (sv) * | 2002-11-12 | 2002-11-12 | Astrazeneca Ab | New use |
SI1569912T1 (sl) | 2002-12-03 | 2015-09-30 | Pharmacyclics Llc | Derivati 2-(2-hidroksibifenil-3-il)-1h-benzoimidazol-5-karboksamidina kot inhibitorji faktorja viia |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4464175A (en) * | 1982-08-25 | 1984-08-07 | Altman Alan R | Multipurpose tamponade and thrombosclerotherapy tube |
US4568545A (en) * | 1982-10-02 | 1986-02-04 | Amano Seiyaku Kabushiki Kaisha | Thrombolytic agent |
WO1994007472A1 (en) * | 1992-10-02 | 1994-04-14 | Pfizer Inc. | Pharmaceutical compositions containing nonionic surfactants |
SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
SE9302135D0 (sv) * | 1993-06-18 | 1993-06-18 | Kabi Pharmacia Ab | New pharmaceutical composition |
SE9404196D0 (sv) * | 1994-12-02 | 1994-12-02 | Astra Ab | New antithrombotic formulation |
-
1996
- 1996-05-31 SE SE9602145A patent/SE9602145D0/xx unknown
-
1997
- 1997-05-01 ID IDP971453A patent/ID19472A/id unknown
- 1997-05-20 ZA ZA9704386A patent/ZA974386B/xx unknown
- 1997-05-20 AR ARP970102135A patent/AR013569A1/es not_active Application Discontinuation
- 1997-05-28 WO PCT/SE1997/000914 patent/WO1997045138A1/en active IP Right Grant
- 1997-05-28 EP EP97926326A patent/EP1015022B1/de not_active Expired - Lifetime
- 1997-05-28 NZ NZ332788A patent/NZ332788A/xx unknown
- 1997-05-28 DE DE69731981T patent/DE69731981T2/de not_active Expired - Fee Related
- 1997-05-28 AU AU31115/97A patent/AU722450B2/en not_active Ceased
- 1997-05-28 CA CA002253410A patent/CA2253410A1/en not_active Abandoned
- 1997-05-28 US US08/894,615 patent/US6673365B1/en not_active Expired - Fee Related
- 1997-05-28 JP JP09542227A patent/JP2000511526A/ja not_active Ceased
- 1997-05-28 AT AT97926326T patent/ATE284706T1/de not_active IP Right Cessation
-
1998
- 1998-11-27 NO NO985558A patent/NO985558D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2000511526A (ja) | 2000-09-05 |
NZ332788A (en) | 2000-05-26 |
NO985558L (no) | 1998-11-27 |
US6673365B1 (en) | 2004-01-06 |
CA2253410A1 (en) | 1997-12-04 |
EP1015022A1 (de) | 2000-07-05 |
DE69731981T2 (de) | 2005-12-22 |
EP1015022B1 (de) | 2004-12-15 |
NO985558D0 (no) | 1998-11-27 |
ATE284706T1 (de) | 2005-01-15 |
AU722450B2 (en) | 2000-08-03 |
ID19472A (id) | 1998-07-16 |
AU3111597A (en) | 1998-01-05 |
DE69731981D1 (de) | 2005-01-20 |
AR013569A1 (es) | 2001-01-10 |
WO1997045138A1 (en) | 1997-12-04 |
ZA974386B (en) | 1997-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9404196D0 (sv) | New antithrombotic formulation | |
PT966447E (pt) | Moleculas pequenas uteis no tratamento de doencas inflamatorias | |
ATE305788T1 (de) | (s,s)-reboxetin zur behandlung von inkontinenz | |
GB9818916D0 (en) | Use | |
NO20075066L (no) | Farmasoytisk sammensetning som inneholder isoflavoner | |
NZ337211A (en) | Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors | |
TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
DE60112766D1 (de) | Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen | |
DE60310400D1 (de) | Botulinustoxine zur behandlung von priapismus | |
DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
FI103111B1 (fi) | Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
SE9602145D0 (sv) | New improved formulation for treatment of thromboembolism | |
NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
BR0015402A (pt) | Derivados de ácido 15-hidroxieicosatetraenóico de cadeia Èmega modificada e métodos de seu uso para o tratamento de olho seco | |
ATE215941T1 (de) | Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
NO970185L (no) | Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi | |
DK0968174T3 (da) | Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok | |
DE69824862D1 (de) | Zusammenstellungen zur verbesserten wundheilung | |
DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
RU96119673A (ru) | Способ лечения болевого синдрома | |
ID28174A (id) | Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya | |
EA199800822A1 (ru) | Способ лечения избыточной агрессии | |
NO981594L (no) | Behandling av infeksjoner forÕrsaket av Helicobacter pylori |